FAM120A

Across TCGA pan-cancer cohorts, FAM120A mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of FAM120A’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where FAM120A mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types FAM120A is over-expressed in tumor, although a few such as CCRCC show the opposite, repressed pattern.

HNSC, LUAD, and CCRCC are the cancer types where FAM120A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM120A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.178	<.001	11	view →
LUAD	Female	III,IV	+0.358	<.001	8	view →
CCRCC	All	All	−0.061	<.001	8	view →
COAD	All	All	+0.074	<.001	7	view →
LSCC	Male	All	+0.080	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

FAM120A–HNSC

Open the HNSC breakdown →